Skip to content

Relationship of Essential Hypertension and Its Treatments on the Postoperative Pain Management: a Prospective, Observational, Cross-sectional Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02244177
Enrollment
300
Registered
2014-09-18
Start date
2013-11-30
Completion date
Unknown
Last updated
2015-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Numbers of postoperative PCA related side effects among three groups will be determined by comparing and analyzing frequency distributions. To determine whether the patients with hypertension require less post operative opiate analgesics than others, multivariate analysis with repeated measures will be performed to identify the major and the minor factors predicting the use of postoperative pain therapy. The major aim of the study is to test the hypothesis that the morphine comsumpted by the hypertension group is less than those of the normotension group. The minor aims for the study are the difference related to pain intensity, or the incidence of side effects among groups.

Interventions

None listed

Sponsors

Kaohsiung Veterans General Hospital.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 300 eligible subjects * No contraindication for inhalation anesthesia * Elective surgery * Age between 20-75 y/o * No contraindication for postoperative morphine pain control * Female or male * Essential hypertension stage I and II (140\<=SBP\<=180; 90\<=DBP\<=110)

Exclusion criteria

* Liver disease * Renal disease * Those who is presumed to go to ICU after surgery * The patients with dementia or conscious disturbance * Pregnancy or breast feeding * Secondary hypertension * events in recent 6 months myocardial infarction cardiac bypass surgery unstable angina cerebrovascular events congestive heart failure significant arrhythmia thoracic surgery

Design outcomes

Primary

MeasureTime frame
PainPost-operation Day1 to Day4

Secondary

MeasureTime frame
Morphine consumptionPost-operation Day1 to Day4

Other

MeasureTime frame
side effectsPost-operation Day1 to Day4

Countries

Taiwan

Contacts

Primary ContactYuan Yi Chia, Bachelor
yychia@isca.vghks.gov.tw88673468183

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026